Article info
PostScript
Letters
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5
- Correspondence to Professor Francesco Negro, Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospitals, 4 rue Gabrielle-Perret-Gentil, CH-1211 Geneva 14, Switzerland; francesco.negro{at}hcuge.ch
Citation
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5
Publication history
- Accepted January 12, 2012
- First published February 16, 2012.
Online issue publication
January 09, 2022
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions